S&P 500

5.460,48

-0,41%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Nucryst Pharmaceuticals - Common Shares (MM) (NCST)
Nucryst Pharmaceuticals - Common Shares (MM) (NCST) Notícias

NCST

Nucryst (NCST)

Nucryst Pharmaceuticals - Common Shares (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:NCST

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
08/02/2010	20:20	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
08/02/2010	17:13	PR Newswire (US)	NUCRYST Announces Completion of Amalgamation	NASDAQ:NCST
15/01/2010	20:25	Edgar (US Regulatory)	Amended Statement of Ownership: Private Transaction (SC 13E3/A)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
15/01/2010	19:33	PR Newswire (US)	NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders	NASDAQ:NCST
31/12/2009	17:00	PR Newswire (US)	NUCRYST Announces Further Adjournment of Special Shareholder Meeting	NASDAQ:NCST
29/12/2009	19:54	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
22/12/2009	19:45	PR Newswire (US)	Smith & Nephew Completes Acquisition of the Assets of Nucryst Pharmaceuticals Corp.	NASDAQ:NCST
22/12/2009	16:57	PR Newswire (US)	NUCRYST Announces the Completion of the Sale of its Acticoat Business	NASDAQ:NCST
02/12/2009	15:35	Edgar (US Regulatory)	Statement of Ownership: Private Transaction (SC 13E3)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
20/11/2009	21:18	PR Newswire (US)	NUCRYST Announces Special Meeting of Shareholders	NASDAQ:NCST
16/11/2009	09:04	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
13/11/2009	19:47	PR Newswire (US)	NUCRYST announces 2009 third quarter financial results	NASDAQ:NCST
11/11/2009	08:36	Dow Jones News	Smith & Nephew Buys Nucryst Pharma Assets For Initial $21 Million	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
10/11/2009	22:15	PR Newswire (US)	NUCRYST Announces Agreement to Sell Acticoat Business and Proposes Amalgamation with Westaim	NASDAQ:NCST
18/09/2009	18:11	PR Newswire (US)	NUCRYST Receives Deficiency Notice from NASDAQ	NASDAQ:NCST
03/09/2009	11:19	PR Newswire (US)	European Launch of Acticoat(TM) Flex with NUCRYST's Nanocrystalline Silver Technology Announced by Smith Nephew	NASDAQ:NCST
05/08/2009	08:00	PR Newswire (US)	NUCRYST announces 2009 second quarter financial results	NASDAQ:NCST
29/07/2009	10:00	PR Newswire (US)	New ACTICOAT(TM) Silver Coated Anti-microbial Barrier Dressing Receives 510(k) Clearance from the US FDA	NASDAQ:NCST
21/07/2009	17:30	PR Newswire (US)	Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter Results	NASDAQ:NCST
06/05/2009	08:00	PR Newswire (US)	NUCRYST announces 2009 first quarter financial results	NASDAQ:NCST
29/04/2009	18:26	PR Newswire (US)	Conference Call Advisory - NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results	NASDAQ:NCST
19/02/2009	08:03	Edgar (US Regulatory)	Annual Report (10-K)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
17/02/2009	09:00	PR Newswire (US)	NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results	NASDAQ:NCST
12/02/2009	15:51	PR Newswire (US)	NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders	NASDAQ:NCST
19/01/2009	17:31	PR Newswire (US)	NUCRYST appoints interim CEO	NASDAQ:NCST
16/01/2009	11:00	PR Newswire (US)	NUCRYST Pharmaceuticals appoints a new director	NASDAQ:NCST
31/12/2008	14:59	Edgar (US Regulatory)	Amended Current report filing (8-K/A)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
19/12/2008	17:01	PR Newswire (US)	NUCRYST calls special meeting of shareholders	NASDAQ:NCST
11/12/2008	13:42	Edgar (US Regulatory)	Confidential Treatment Order (CT ORDER)	NASDAQ:NCST	Nucryst Pharmaceuticals - Common Shares (MM)
02/12/2008	12:46	PR Newswire (US)	NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder	NASDAQ:NCST